Publication: Evaluation of the toxic effects of thimerosal and/or aluminum hydroxide in SH-SY5Y cell line
| dc.contributor.author | Öztürk, Mehmet Evren | |
| dc.contributor.author | Yi̇Rün, Anıl | |
| dc.contributor.author | Erdemli̇-Köse, Selinay Başak | |
| dc.contributor.author | Özyurt, Aylin Balcı | |
| dc.contributor.author | Çakır, Deniz Arca | |
| dc.contributor.author | Oral, Didem | |
| dc.contributor.author | Erkekoǧlu, Pínar | |
| dc.contributor.institution | Öztürk, Mehmet Evren, Department of Pharmacology and Toxicology, Hacettepe Üniversitesi, Ankara, Turkey | |
| dc.contributor.institution | Yi̇Rün, Anıl, Department of Pharmacology and Toxicology, Hacettepe Üniversitesi, Ankara, Turkey, Department of Pharmacology and Toxicology, Çukurova Üniversitesi, Adana, Turkey | |
| dc.contributor.institution | Erdemli̇-Köse, Selinay Başak, Department of Pharmacology and Toxicology, Hacettepe Üniversitesi, Ankara, Turkey, Department of Chemistry, Burdur Mehmet Akif Ersoy Üniversitesi, Burdur, Turkey | |
| dc.contributor.institution | Özyurt, Aylin Balcı, Department of Pharmacology and Toxicology, Hacettepe Üniversitesi, Ankara, Turkey, Department of Pharmacology and Toxicology, Bahçeşehir Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Çakır, Deniz Arca, Department of Pharmacology and Toxicology, Hacettepe Üniversitesi, Ankara, Turkey, Department of Vaccine Technology, Hacettepe Üniversitesi, Ankara, Turkey | |
| dc.contributor.institution | Oral, Didem, Department of Pharmacology and Toxicology, Hacettepe Üniversitesi, Ankara, Turkey, Department of Pharmacology and Toxicology, Düzce Üniversitesi, Duzce, Turkey | |
| dc.contributor.institution | Erkekoǧlu, Pínar, Department of Pharmacology and Toxicology, Hacettepe Üniversitesi, Ankara, Turkey, Department of Pharmacology and Toxicology, Bahçeşehir Üniversitesi, Istanbul, Turkey | |
| dc.date.accessioned | 2025-10-05T15:22:17Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | In this study, we aimed to evaluate possible toxic effects of thimerosal, aluminum and combination of thimerosal and aluminum in SH-SY5Y cells. Inhibitory concentrations were determined by MTT assay, reactive oxygen species (ROS) were determined by a fluorometric kit and antioxidant/oxidant parameters were measured by spectrophotometric kits. Nuclear factor erythroid 2-associated factor 2 (Nrf2), norepinephrine (NE), dopamine transporter (DAT) and dopamine beta β-hydroxylase (DBH) levels were measured by sandwich ELISA kits while 8-hydroxy deoxyguanosine (8-OHdG) and dopamine levels were determined by competitive ELISA kits. Thimerosal (1.15 μM) and aluminum (362 μM) were applied to cells at inhibitory concentrations 20 (IC<inf>20</inf>s) for 24 h. ROS increased significantly in cells aluminum- and aluminum+thimerosal-treated cells. Glutathione levels decreased in aluminum group while total antioxidant capacity and protein oxidation levels increased significantly in aluminum and aluminum+thimerosal groups. Lipid peroxidation increased significantly in groups treated with aluminum and aluminum+thimerosal. Nrf2 levels and DNA damage were significantly higher in all groups while dopamine levels significantly increased in cells treated with thimerosal and aluminum+thimerosal, DAT levels were found to be higher in all experimental groups compared to the control. These findings showed that both thimerosal and aluminum can change oxidant/antioxidant status, cause DNA damage, alter dopamine and DAT levels. Changes seen in cells treated with combined exposure to aluminum and thimerosal are more pronounced. Special care should be taken while vaccinating sensitive populations and safer alternatives for aluminum and thimerosal should used. © 2023 Elsevier B.V., All rights reserved. | |
| dc.identifier.doi | 10.1177/09603271221136206 | |
| dc.identifier.issn | 09603271 | |
| dc.identifier.pubmed | 36411272 | |
| dc.identifier.scopus | 2-s2.0-85142351697 | |
| dc.identifier.uri | https://doi.org/10.1177/09603271221136206 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14719/9027 | |
| dc.identifier.volume | 41 | |
| dc.language.iso | en | |
| dc.publisher | SAGE Publications Ltd | |
| dc.relation.oastatus | All Open Access | |
| dc.relation.oastatus | Gold Open Access | |
| dc.relation.oastatus | Green Accepted Open Access | |
| dc.relation.oastatus | Green Open Access | |
| dc.relation.source | Human and Experimental Toxicology | |
| dc.subject.authorkeywords | Aluminum | |
| dc.subject.authorkeywords | Neurotoxicity | |
| dc.subject.authorkeywords | Oxidative Damage | |
| dc.subject.authorkeywords | Thimerosal | |
| dc.subject.authorkeywords | Vaccine | |
| dc.subject.authorkeywords | Aluminum Hydroxide | |
| dc.subject.authorkeywords | Glutathione Peroxidase | |
| dc.subject.authorkeywords | Glutathione Reductase | |
| dc.subject.authorkeywords | Aluminum | |
| dc.subject.authorkeywords | Dopamine | |
| dc.subject.authorkeywords | Thiomersal | |
| dc.subject.authorkeywords | Aluminum | |
| dc.subject.authorkeywords | Aluminum Hydroxide | |
| dc.subject.authorkeywords | Antioxidants | |
| dc.subject.authorkeywords | Dopamine | |
| dc.subject.authorkeywords | Nf-e2-related Factor 2 | |
| dc.subject.authorkeywords | Oxidants | |
| dc.subject.authorkeywords | Reactive Oxygen Species | |
| dc.subject.authorkeywords | Thimerosal | |
| dc.subject.authorkeywords | 8 Hydroxydeoxyguanosine | |
| dc.subject.authorkeywords | Aluminum Hydroxide | |
| dc.subject.authorkeywords | Glutathione Peroxidase | |
| dc.subject.authorkeywords | Glutathione Reductase | |
| dc.subject.authorkeywords | Thiobarbituric Acid Reactive Substance | |
| dc.subject.authorkeywords | Transcription Factor Nf E2 P45 Subunit | |
| dc.subject.authorkeywords | Transcription Factor Nrf2 | |
| dc.subject.authorkeywords | Aluminum | |
| dc.subject.authorkeywords | Antioxidant | |
| dc.subject.authorkeywords | Dopamine | |
| dc.subject.authorkeywords | Oxidizing Agent | |
| dc.subject.authorkeywords | Reactive Oxygen Metabolite | |
| dc.subject.authorkeywords | Thiomersal | |
| dc.subject.authorkeywords | Antioxidant Activity | |
| dc.subject.authorkeywords | Article | |
| dc.subject.authorkeywords | Bone Tumor | |
| dc.subject.authorkeywords | Cell Viability | |
| dc.subject.authorkeywords | Competitive Elisa | |
| dc.subject.authorkeywords | Controlled Study | |
| dc.subject.authorkeywords | Dna Damage | |
| dc.subject.authorkeywords | Enzyme Linked Immunosorbent Assay | |
| dc.subject.authorkeywords | Gene Expression | |
| dc.subject.authorkeywords | Human | |
| dc.subject.authorkeywords | Inhibitory Concentration | |
| dc.subject.authorkeywords | Lipid Peroxidation | |
| dc.subject.authorkeywords | Lipid Peroxidation Assay | |
| dc.subject.authorkeywords | Mtt Assay | |
| dc.subject.authorkeywords | Oxidative Stress | |
| dc.subject.authorkeywords | Sandwich Elisa | |
| dc.subject.authorkeywords | Sh-sy5y Cell Line | |
| dc.subject.authorkeywords | Spectrophotometry | |
| dc.subject.authorkeywords | Spectroscopy | |
| dc.subject.authorkeywords | Total Antioxidant Capacity | |
| dc.subject.authorkeywords | Tumor Biopsy | |
| dc.subject.authorkeywords | Cell Line | |
| dc.subject.authorkeywords | Metabolism | |
| dc.subject.authorkeywords | Neuroblastoma | |
| dc.subject.authorkeywords | Aluminum | |
| dc.subject.authorkeywords | Aluminum Hydroxide | |
| dc.subject.authorkeywords | Antioxidants | |
| dc.subject.authorkeywords | Cell Line | |
| dc.subject.authorkeywords | Dopamine | |
| dc.subject.authorkeywords | Humans | |
| dc.subject.authorkeywords | Neuroblastoma | |
| dc.subject.authorkeywords | Nf-e2-related Factor 2 | |
| dc.subject.authorkeywords | Oxidants | |
| dc.subject.authorkeywords | Reactive Oxygen Species | |
| dc.subject.authorkeywords | Thimerosal | |
| dc.subject.indexkeywords | 8 hydroxydeoxyguanosine | |
| dc.subject.indexkeywords | aluminum hydroxide | |
| dc.subject.indexkeywords | glutathione peroxidase | |
| dc.subject.indexkeywords | glutathione reductase | |
| dc.subject.indexkeywords | thiobarbituric acid reactive substance | |
| dc.subject.indexkeywords | transcription factor NF E2 p45 subunit | |
| dc.subject.indexkeywords | transcription factor Nrf2 | |
| dc.subject.indexkeywords | aluminum | |
| dc.subject.indexkeywords | antioxidant | |
| dc.subject.indexkeywords | dopamine | |
| dc.subject.indexkeywords | oxidizing agent | |
| dc.subject.indexkeywords | reactive oxygen metabolite | |
| dc.subject.indexkeywords | thiomersal | |
| dc.subject.indexkeywords | antioxidant activity | |
| dc.subject.indexkeywords | Article | |
| dc.subject.indexkeywords | bone tumor | |
| dc.subject.indexkeywords | cell viability | |
| dc.subject.indexkeywords | competitive ELISA | |
| dc.subject.indexkeywords | controlled study | |
| dc.subject.indexkeywords | DNA damage | |
| dc.subject.indexkeywords | enzyme linked immunosorbent assay | |
| dc.subject.indexkeywords | gene expression | |
| dc.subject.indexkeywords | human | |
| dc.subject.indexkeywords | inhibitory concentration | |
| dc.subject.indexkeywords | lipid peroxidation | |
| dc.subject.indexkeywords | lipid peroxidation assay | |
| dc.subject.indexkeywords | MTT assay | |
| dc.subject.indexkeywords | oxidative stress | |
| dc.subject.indexkeywords | sandwich ELISA | |
| dc.subject.indexkeywords | SH-SY5Y cell line | |
| dc.subject.indexkeywords | spectrophotometry | |
| dc.subject.indexkeywords | spectroscopy | |
| dc.subject.indexkeywords | total antioxidant capacity | |
| dc.subject.indexkeywords | tumor biopsy | |
| dc.subject.indexkeywords | cell line | |
| dc.subject.indexkeywords | metabolism | |
| dc.subject.indexkeywords | neuroblastoma | |
| dc.subject.indexkeywords | Aluminum | |
| dc.subject.indexkeywords | Aluminum Hydroxide | |
| dc.subject.indexkeywords | Antioxidants | |
| dc.subject.indexkeywords | Cell Line | |
| dc.subject.indexkeywords | Dopamine | |
| dc.subject.indexkeywords | Humans | |
| dc.subject.indexkeywords | Neuroblastoma | |
| dc.subject.indexkeywords | NF-E2-Related Factor 2 | |
| dc.subject.indexkeywords | Oxidants | |
| dc.subject.indexkeywords | Reactive Oxygen Species | |
| dc.subject.indexkeywords | Thimerosal | |
| dc.title | Evaluation of the toxic effects of thimerosal and/or aluminum hydroxide in SH-SY5Y cell line | |
| dc.type | Article | |
| dcterms.references | undefined, (1989), Pharmaceutical Biotechnology, (1992), Recombinant Vectors in Vaccine Development Symposium, (1993), Pollard, Andrew J., A guide to vaccinology: from basic principles to new developments, Nature Reviews Immunology, 21, 2, pp. 83-100, (2021), Apostólico, Juliana de Souza, Adjuvants: Classification, Modus Operandi, and Licensing, Journal of Immunology Research, 2016, (2016), Cocuk Sal Ve Hastalklar Dergisi, (2008), Petrovsky, Nikolai P., Vaccine adjuvants: Current state and future trends, Immunology and Cell Biology, 82, 5, pp. 488-496, (2004), HogenEsch, Harm, Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want, npj Vaccines, 3, 1, (2018), Petrovsky, Nikolai P., Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs, Drug Safety, 38, 11, pp. 1059-1074, (2015), O'Hagan, Derek T., The safety of vaccines, Drug Discovery Today, 9, 19, pp. 846-854, (2004) | |
| dspace.entity.type | Publication | |
| local.indexed.at | Scopus | |
| person.identifier.scopus-author-id | 35964476500 | |
| person.identifier.scopus-author-id | 57211079309 | |
| person.identifier.scopus-author-id | 57448659200 | |
| person.identifier.scopus-author-id | 59711451100 | |
| person.identifier.scopus-author-id | 57482646800 | |
| person.identifier.scopus-author-id | 57188932723 | |
| person.identifier.scopus-author-id | 35239631400 |
